Not a good buy right now for an impatient buyer: price is still in a strong downtrend and sits below/near key support, so the path of least resistance remains lower.
A short-term oversold bounce is possible (RSI extremely oversold + call-skewed options activity), but with earnings on 2026-02-05 pre-market, near-term direction is event-driven and difficult to handicap.
Momentum: MACD histogram -0.864 and negatively expanding = bearish momentum is strengthening, not stabilizing yet.
Mean-reversion setup: RSI_6 at 6.599 = extremely oversold, increasing odds of a snapback rally, but oversold can persist in strong downtrends.
Key levels: Pre-market ~27.79 is below S1 (28.329), implying prior support has likely flipped to resistance; next support S2 ~25.289. Pivot resistance is much higher at ~33.249.
Pattern/stat bias (similar candlesticks): modest bullish drift probabilities, but small expected returns (next day +0.41%, week +1.87%, month +3.2%) that don’t negate the current downtrend.
Activity: Today’s options volume is elevated (today vs 30d avg ~181%), suggesting heightened speculation/positioning ahead of earnings.
Volatility: IV_30d ~93.77 vs HV ~69.66; IV percentile ~83 = options are expensive and market is pricing a large move (earnings/event premium).
Skew: Calls dominate volume (11,810 calls vs 3,067 puts), consistent with traders leaning rebound/upside into the event.
Technical Summary
Sell
8
Buy
7
Positive Catalysts
can improve crypto market structure clarity—supportive for exchange platforms.
Neutral/Negative Catalysts
raises questions about durability of growth/earnings quality.
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: 41,599,507,000, down -23.24% YoY (declining top-line trend).
Net Income: 18,397,000, down -127.46% YoY (profitability deteriorated sharply).
EPS: 0.14, down -131.11% YoY.
Gross Margin: 0.03, down -25.00% YoY.
Near-term setup: market focus shifts to Q4 2025 results on 2026-02-05 pre-market, with expectations for improved profitability per news preview.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: price targets have generally moved down, even when ratings stayed constructive—reflecting multiple compression and/or lower near-term expectations.
Latest note: JPMorgan (2026-01-27) kept Neutral and cut PT to $42 from $45.
Constructive but cutting targets: Citi kept Buy but cut PT to $67 from $77; Canaccord kept Buy but cut PT to $50 from $68; Clear Street kept/raised to Buy with PT $57 (down from $60 previously).
Wall Street cons: sensitivity to crypto prices/volumes, guidance-driven volatility, and valuation resets implied by repeated PT cuts.
Influential/political trading: No politician/congress trading data in the last 90 days; hedge funds and insiders flagged as Neutral with no notable recent trend.
Wall Street analysts forecast BLSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLSH is 54 USD with a low forecast of 45 USD and a high forecast of 67 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast BLSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLSH is 54 USD with a low forecast of 45 USD and a high forecast of 67 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 24.900
Low
45
Averages
54
High
67
Current: 24.900
Low
45
Averages
54
High
67
Clear Street
Owen Lau
Buy
downgrade
$50 -> $42
AI Analysis
2026-02-06
New
Reason
Clear Street
Owen Lau
Price Target
$50 -> $42
AI Analysis
2026-02-06
New
downgrade
Buy
Reason
Clear Street analyst Owen Lau lowered the firm's price target on Bullish to $42 from $50 and keeps a Buy rating on the shares. The company reported strong Q4 results and the fiscal 2026 outlook is solid, the analyst tells investors in a research note. Clear cites the "risk-off" environment, weak investor sentiment, and uncertainty surrounding the timing of market structure legislation for the target cut.
JPMorgan
Neutral
downgrade
$42 -> $41
2026-02-06
New
Reason
JPMorgan
Price Target
$42 -> $41
2026-02-06
New
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Bullish to $41 from $42 and keeps a Neutral rating on the shares. The firm views the company's Q4 report as inline.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BLSH
